These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6184812)

  • 1. Interactions between body fluids, chemotherapeutic agents and interferon.
    Cesario TC; Tilles JG
    Tex Rep Biol Med; 1981-1982; 41():259-62. PubMed ID: 6184812
    [No Abstract]   [Full Text] [Related]  

  • 2. Inactivation of human interferon by body fluids.
    Cesario TC; Tilles JG
    Tex Rep Biol Med; 1977; 35():443-8. PubMed ID: 616673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of interferon in body fluids and tissues.
    Bocci V
    Tex Rep Biol Med; 1977; 35():436-42. PubMed ID: 358467
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of interferons. A reappraisal.
    Bocci V
    Tex Rep Biol Med; 1981-1982; 41():336-43. PubMed ID: 6184823
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon in nasopharyngeal sections.
    Lancet; 1982 Jan; 1(8262):44-5. PubMed ID: 6172682
    [No Abstract]   [Full Text] [Related]  

  • 6. Transformation of mouse fibroblasts alters the induction pattern of type I IFNs after virus infection.
    Samuelsson CV; Lienenklaus S; Müller PP; Zawatzky R; Hauser H; Weiss S
    Biochem Biophys Res Commun; 2005 Sep; 335(2):584-9. PubMed ID: 16091286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current problems on interferon research].
    Kishida T
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):10-5. PubMed ID: 6198963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoblotting characterization of CA 125 in biological fluids: difference between pregnancy and cancer CA 125 origin.
    Barbati A; Lauro V; Orlacchio A; Cosmi EV
    Anticancer Res; 1996; 16(6B):3621-4. PubMed ID: 9042231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species specificity of interferon.
    Gillespie D; Carter WA
    Tex Rep Biol Med; 1981-1982; 41():37-42. PubMed ID: 6184826
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacological aspects of interferon therapy in man.
    Billiau A
    Acta Microbiol Acad Sci Hung; 1981; 28(3):257-62. PubMed ID: 6171139
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental research to clinical application of interferons].
    Imamishi J; Tanaka A
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):53-9. PubMed ID: 6198966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the monitoring of human interferon in body fluids and the phenotypic expression of human interferon activity.
    Mitchell WM; Forti RL
    Prog Clin Pathol; 1984; 9():101-19. PubMed ID: 6198690
    [No Abstract]   [Full Text] [Related]  

  • 13. The production of prostaglandins and thromboxanes in the feto-placental unit and their effects on the developing fetus.
    Challis JR; Patrick JE
    Semin Perinatol; 1980 Jan; 4(1):23-33. PubMed ID: 6992278
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferons as anticancer agents.
    Brodsky I; Hubbell HR
    Am Fam Physician; 1984 Jun; 29(6):246-8. PubMed ID: 6203394
    [No Abstract]   [Full Text] [Related]  

  • 15. Assay of 3-nitrotyrosine in tissues and body fluids by liquid chromatography with tandem mass spectrometric detection.
    Rabbani N; Thornalley PJ
    Methods Enzymol; 2008; 440():337-59. PubMed ID: 18423229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated protein kinase pathways in interferon signaling.
    Sassano A; Verma A; Platanias LC
    Methods Mol Med; 2005; 116():135-50. PubMed ID: 16000859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of human interferons: an overview.
    Mizrahi A
    Dev Biol Stand; 1983; 55():219-30. PubMed ID: 6203796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of body fluids and angiotensin II receptors in a rat model of intra-uterine growth restriction.
    Bédard S; Sicotte B; St-Louis J; Brochu M
    J Physiol; 2005 Feb; 562(Pt 3):937-50. PubMed ID: 15539403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferons and cancer: how the promise is being kept.
    Borden EC
    Interferon; 1983; 5():43-83. PubMed ID: 6202643
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genes.
    O'Doherty C; Villoslada P; Vandenbroeck K
    Cytokine Growth Factor Rev; 2007; 18(3-4):211-22. PubMed ID: 17540610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.